Pro Medicus (PME.AX) Osake Kurssi
Pro Medicus Kurssi
Liikevaihto on kasvanut 17,3 % vuodessa viimeisten 19 vuoden aikana 261,69 M AUD:een. Osakekohtainen tulos on kasvanut 20,8 % vuodessa viimeisten 19 vuoden aikana. Pro Medicusn nettomarginaali on nyt 101,4 %, noussut 47,6 %:sta muutama vuosi sitten. Pro Medicusn osinkotuotto on tällä hetkellä noin 0,46 %. Jakosuhde on noin 73 % tuloksesta. Osinko on kasvanut 21,6 % vuodessa viimeisten 19 vuoden aikana. Analyytikoiden mediaanitavoitehinta on 244,80 AUD, eli yli nykyhintaa 27,9 %. 17 analyytikosta 11 suosittaa ostoa — kokonaiskonsensus on Osta.
Pro Medicus osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Pro Medicus liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Pro Medicus -osakkeesta
The business model of Pro Medicus Ltd revolves around providing advanced healthcare imaging software solutions. The company specializes in developing and delivering a comprehensive range of radiology solutions that enhance workflow efficiency and improve patient care. Pro Medicus offers cutting-edge products like Visage AI, Visage 7, and Visage RIS, which allow healthcare professionals to efficiently manage and analyze medical images. By combining innovative technology with a customer-centric approach, Pro Medicus helps healthcare providers worldwide optimize their imaging operations and deliver accurate diagnoses. With its focus on developing state-of-the-art software solutions, Pro Medicus positions itself as a leader in the medical imaging industry.
Pro Medicus Ltd is primarily active in the healthcare industry.
The main competitors of Pro Medicus Ltd in the market include other medical imaging companies such as Carestream Health, Change Healthcare, and Sectra AB. These companies also specialize in providing medical imaging solutions and technology to healthcare providers and are prominent players in the industry. Pro Medicus Ltd competes with them in terms of product offerings, innovation, customer base, and market share.
Pro Medicus Ltd is a renowned healthcare imaging and information technology provider. Established in 1983, the company has a rich history of pioneering innovative solutions in the medical imaging industry. With a strong focus on radiology, Pro Medicus has developed advanced imaging software that improves efficiency and enhances patient care. The company's success is attributed to its commitment to research and development, resulting in cutting-edge technologies and multiple industry awards. Pro Medicus operates globally, serving prominent healthcare institutions and professionals. With its profound expertise and dedication to advancing medical imaging technology, Pro Medicus Ltd continues to lead the industry in providing innovative solutions for the healthcare sector.
Some significant milestones achieved by Pro Medicus Ltd include the successful expansion into major global markets, such as the United States and Europe, further solidifying its position as a leading provider of healthcare imaging solutions. The company has also experienced continuous revenue growth, achieving record-breaking financial results year after year. Pro Medicus Ltd has consistently developed and released innovative software solutions, enhancing efficiency and productivity for healthcare professionals. Additionally, the company has formed strategic partnerships with top-tier healthcare organizations, further establishing its reputation as a trusted industry leader. These accomplishments have propelled Pro Medicus Ltd's growth and success in the competitive healthcare technology sector.
Pro Medicus Ltd primarily operates in Australia and the United States.
Pro Medicus Ltd is a leading healthcare IT solutions provider with a strong commitment to excellence and innovation. The company's core values revolve around delivering exceptional products and services that empower healthcare professionals to enhance patient care and outcomes. Pro Medicus emphasizes a customer-centric approach and strives to provide customized solutions tailored to meet the unique needs of its clients. With a clear focus on technological advancements and high-quality imaging software, Pro Medicus constantly pushes the boundaries in the healthcare industry. By fostering a culture of collaboration and continuous improvement, Pro Medicus Ltd is dedicated to transforming the way medical images are managed and shared worldwide.
Analyytikot asettavat tällä hetkellä Pro Medicus-osakkeelle keskimääräisen tavoitehinnan 226,59 AUD (mediaani: 244,80 AUD), mikä merkitsee +18,4 % viimeisimpään hintaan verrattuna. Konsensus perustuu 17 analyytikkoarvioon.
17 analyytikkoa arvioi tällä hetkellä Pro Medicus-osaketta: 13 suosittaa ostoa, 4 pitoa ja 0 myyntiä.
Nykyisellä valuuttakurssilla Pro Medicus-osake noteerataan hintaan 119,18 EUR (191,33 AUD).
Pro Medicus-osake (PME.AX) on listattuna 3 pörssissä, muun muassa: ASX (PME.AX), Frankfurt (PMC.F).
Pro Medicus Ltd is a global company specializing in providing advanced IT solutions for the healthcare industry. They offer innovative information and image management solutions that are used by leading healthcare organizations worldwide. Their main divisions include Picture Archiving and Communication Systems (PACS), Radiology Information Systems (RIS), and Telemedicine. Their PACS solutions allow hospitals and healthcare organizations to store, manage, and share digital images from medical diagnostic devices such as CT, MRI, and X-ray machines. These solutions are scalable and provide high-quality image quality for radiologists and other specialists to make informed diagnoses. Their RIS is an integrated solution designed specifically for radiology departments and practices, providing complete patient and order management, as well as integrated workflow tools to improve the efficiency and accuracy of diagnosing and evaluating medical imaging data. Their telemedicine solutions enable radiology professionals to edit and share medical images remotely over the internet, particularly beneficial in facilities with limited resources or for quick access to medical images in emergency diagnoses. In addition, Pro Medicus Ltd also offers specialized solutions for clinical decision support, automated medical image analysis, and patient management. Their clinical decision support provides assistance to medical professionals in diagnosis and treatment monitoring, while the automated analysis of medical image data allows for the quick processing of large amounts of data, producing results that can be utilized by professionals for diagnostic purposes. Their patient management solutions provide comprehensive capture and management of health data that can be used by doctors and other professionals to develop better treatment options for their patients. Pro Medicus Ltd is a global company with a strong focus on research and development. They have partnerships with leading healthcare organizations worldwide and possess a strong portfolio of intellectual property. Their business model is based on the sale of products and services specifically designed for the needs of the healthcare industry. The company emphasizes innovation, customer satisfaction, and delivering high-quality solutions that are scalable and flexible for various users. Overall, Pro Medicus Ltd is an innovative market leader in the field of medical IT solutions. They are globally recognized for their products and services and are expected to continue playing a significant role in the healthcare industry.
liikevaihto Pro Medicus on 261,69 M AUD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
voitto Pro Medicus on 265,34 M AUD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Pro Medicus:n hinta-voitto-suhde (P/E) on tällä hetkellä 75,45. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Pro Medicus-osakkeen arvostusta.
Pro Medicus:n hinta-myynti-suhde (P/S) on tällä hetkellä 76,51. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Pro Medicus-osakkeen arvostuskennuslukuna.
Pro Medicus:n Eulpool-laatuscore on 10/10.
Pro Medicus:n ISIN on AU000000PME8. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Pro Medicus:n WKN on 591723. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Pro Medicus:n ticker on PME.AX. Tämä pörssinoteeraus käytetään Pro Medicus-osakkeiden kauppaan pörssissä.
Pro Medicus osake
Pro Medicus vertaisryhmä
Pro Medicus Ticker
Pro Medicus FIGI
Kaikki tunnusluvut ja syvällinen analyysi Pro Medicus:sta
Meidän osakeanalyysimme Pro Medicus-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Pro Medicus:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: